The Phacilitate CNS Leaders Forum is the leading strategic meeting designed for senior R&D and business executives driving the development, registration and launch of novel drugs for neurodegenerative diseases, psychiatric disorders and pain.
In 2012 we will be taking a hard look at the CNS sector, the latest clinical read outs, successes and failures, delivering insights into what the next strategic steps should be, from both R&D and commercial perspectives, to tackle the Achilles heel of target identification and validation in CNS.
Our panels of pharma, biotech, regulators and other key healthcare sector experts will also be debating how to transform translational and clinical development models, end points and rating scales so that they can be better suited to highly variable patient populations.
-Gain a better understanding of the ‘big picture’ in the novel neuroscience world, and of how you must adapt your own decision-making to align with ongoing macro trends and developments
-Improve your R&D strategy through lessons learned and shared in the form of in-depth case studies from genuine thought leaders
-Analyze the evolving marketplace and the CNS R&D business models of your competitors to better differentiate your own product candidates and prepare them for commercial success
-Meet numerous senior R&D decision makers, working in neurodegenerative diseases, psychiatric disorders and pain, from the world’s leading pharm and biotech companies in an exclusive, yet informal environment ideal for networking at the highest levels
-Establish yourself and your organization as frontrunners in the race to deliver the next wave of novel CNS targets